Article info

Download PDFPDF
Overexpression of integrin alpha 2 (ITGA2) correlates with poor survival in patients with pancreatic ductal adenocarcinoma

Authors

  1. Correspondence to Dr Steffen Deichmann, Department of Surgery, University Medical Center Schleswig Holstein Lübeck Campus, 23538 Lubeck, Germany; steffen.deichmann{at}uksh.de
View Full Text

Citation

Deichmann S, Schindel L, Braun R, et al
Overexpression of integrin alpha 2 (ITGA2) correlates with poor survival in patients with pancreatic ductal adenocarcinoma

Publication history

  • Received January 21, 2022
  • Accepted March 7, 2022
  • First published April 8, 2022.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.